Lanean...
Use of pre-treatment MRI scans to predict toxicity from radiotherapy in patients with Glioblastoma (GB)
Median life expectancy of patients with Glioblastoma (GB) is 24.4 weeks. Current best treatment involves concurrent use of Temozolomide and radiotherapy. However, toxicity from radiotherapy can limit patient benefit. The objective of this study was to determine the ability of pre-treatment MRI scans...
Gorde:
| Argitaratua izan da: | Neuro Oncol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790062/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz167.053 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|